{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:51Z","timestamp":1786119411698,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/ico.0b013e3181b55fce","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T00:59:02Z","timestamp":1265936342000},"page":"263-268","source":"Crossref","is-referenced-by-count":9,"title":["Tear Concentration and Safety of Levofloxacin Ophthalmic Solution 1.5% Compared With Ofloxacin Ophthalmic Solution 0.3% After Topical Administration in Healthy Adult Volunteers"],"prefix":"10.1097","volume":"29","author":[{"given":"Thomas","family":"Walters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Rinehart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Holdbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004397-199303340-00007","article-title":"The fluoroquinolones: new antibiotics in ophthalmology.","volume":"33","author":"Ogawa","year":"1993","journal-title":"Int Ophthalmol Clin"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1369-5274(99)00008-9","article-title":"Mechanism of fluoroquinolone action.","volume":"2","author":"Drlica","year":"1999","journal-title":"Curr Opin Microbiol"},{"issue":"Suppl 2","key":"R3-5-20210204","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/314056","article-title":"Mechanisms of action and resistance of older and newer fluoroquinolones.","volume":"31","author":"Hooper","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R4-5-20210204","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/ajhp\/54.22.2569","article-title":"Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?","volume":"54","author":"Ernst","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1345\/aph.17178","article-title":"Levofloxacin and sparfloxacin: new quinolone antibiotics.","volume":"32","author":"Martin","year":"1998","journal-title":"Ann Pharmacother"},{"key":"R6-5-20210204","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00003226-200104000-00012","article-title":"In vitro susceptibilities of bacterial ocular isolates.","volume":"20","author":"Graves","year":"2001","journal-title":"Cornea"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0378-5173(90)90130-V","article-title":"Aqueous solubility of some variously substituted quinolone antimicrobials.","volume":"63","author":"Ross","year":"1990","journal-title":"Int J Pharm"},{"key":"R9-5-20210204","first-page":"4876","article-title":"Effect of ciprofloxacin concentration on mutational resistance rates in S. aureus.","volume":"36","author":"Bui","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-5-20210204","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.iio.0000212132.98760.72","article-title":"Research review and update: IQUIX (levofloxacin 1.5%).","volume":"46","author":"McDonald","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"R12-5-20210204","first-page":"1","article-title":"Ocular TRUST: a new tool for ophthalmology.","volume":"1","author":"Abbott","year":"2007","journal-title":"Ophthalmology Times"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0149-2918(02)80047-9","article-title":"Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers.","volume":"24","author":"Raizman","year":"2002","journal-title":"Clin Ther"},{"key":"R17-5-20210204","first-page":"1","article-title":"Comprehensive evaluation of ocular toxicity of topical levofloxacin in rabbit and primate models.","volume":"23","author":"Clark","year":"2004","journal-title":"J Toxicol Cutaneous Ocul Toxicol"},{"key":"R19-5-20210204","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.jcrs.2005.03.066","article-title":"Safety and efficacy of levofloxacin 1.5% eyedrops in nonhuman primates having penetrating keratoplasty: clinical and laboratory findings.","volume":"31","author":"Gramates","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"R20-5-20210204","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1185\/030079907X242728","article-title":"The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery.","volume":"23","author":"Holland","year":"2007","journal-title":"Curr Med Res Opin"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-201003000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:15:00Z","timestamp":1786040100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201003000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3181b55fce","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}